Cumulative incidence of SARS-CoV-2 infection and associated risk factors among frontline health care workers in Paris: the SEROCOV cohort study.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
04 05 2022
04 05 2022
Historique:
received:
08
10
2021
accepted:
30
03
2022
entrez:
4
5
2022
pubmed:
5
5
2022
medline:
7
5
2022
Statut:
epublish
Résumé
With the COVID-19 pandemic, documenting whether health care workers (HCWs) are at increased risk of SARS-CoV-2 contamination and identifying risk factors is of major concern. In this multicenter prospective cohort study, HCWs from frontline departments were included in March and April 2020 and followed for 3 months. SARS-CoV-2 serology was performed at month 0 (M0), M1, and M3 and RT-PCR in case of symptoms. The primary outcome was laboratory-confirmed SARS-CoV-2 infection at M3. Risk factors of laboratory-confirmed SARS-CoV-2 infection at M3 were identified by multivariate logistic regression. Among 1062 HCWs (median [interquartile range] age, 33 [28-42] years; 758 [71.4%] women; 321 [30.2%] physicians), the cumulative incidence of SARS-CoV-2 infection at M3 was 14.6% (95% confidence interval [CI] [12.5; 16.9]). Risk factors were the working department specialty, with increased risk for intensive care units (odds ratio 1.80, 95% CI [0.38; 8.58]), emergency departments (3.91 [0.83; 18.43]) and infectious diseases departments (4.22 [0.92; 18.28]); current smoking was associated with reduced risk (0.36 [0.21; 0.63]). Age, sex, professional category, number of years of experience in the job or department, and public transportation use were not significantly associated with laboratory-confirmed SARS-CoV-2 infection at M3. The rate of SARS-CoV-2 infection in frontline HCWs was 14.6% at the end of the first COVID-19 wave in Paris and occurred mainly early. The study argues for an origin of professional in addition to private life contamination and therefore including HCWs in the first-line vaccination target population. It also highlights that smokers were at lower risk.Trial registration The study has been registered on ClinicalTrials.gov: NCT04304690 first registered on 11/03/2020.
Identifiants
pubmed: 35508515
doi: 10.1038/s41598-022-10945-y
pii: 10.1038/s41598-022-10945-y
pmc: PMC9068621
doi:
Banques de données
ClinicalTrials.gov
['NCT04304690']
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
7211Informations de copyright
© 2022. The Author(s).
Références
Eur Respir J. 2020 Jul 16;56(1):
pubmed: 32430431
J Clin Microbiol. 2020 Jul 23;58(8):
pubmed: 32381641
JAMA. 2020 Sep 1;324(9):893-895
pubmed: 32780804
JAMA Intern Med. 2020 Dec 1;180(12):1707-1709
pubmed: 32780100
BMJ. 2009 Jun 29;338:b2393
pubmed: 19564179
Clin Infect Dis. 2021 May 4;72(9):1645-1648
pubmed: 32628750
JAMA. 2020 Nov 3;324(17):1781-1782
pubmed: 32940635
MMWR Morb Mortal Wkly Rep. 2020 Sep 04;69(35):1221-1226
pubmed: 32881855
Nicotine Tob Res. 2021 Aug 4;23(8):1436-1440
pubmed: 32964233
Clin Infect Dis. 2021 Nov 2;73(9):e2853-e2860
pubmed: 33011792
Front Med (Lausanne). 2022 Jan 05;8:668995
pubmed: 35071251
Rev Esp Salud Publica. 2021 Oct 22;95:
pubmed: 34675168
Occup Environ Med. 2022 Jun;79(6):388-395
pubmed: 34740981
Addiction. 2021 Jun;116(6):1319-1368
pubmed: 33007104
Ann Intern Med. 2021 May;174(5):649-654
pubmed: 33513035
N Engl J Med. 2020 Oct 29;383(18):1724-1734
pubmed: 32871063
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Front Immunol. 2020 Jun 11;11:1359
pubmed: 32595653
N Engl J Med. 2021 Feb 11;384(6):533-540
pubmed: 33369366
Nicotine Tob Res. 2021 Aug 4;23(8):1398-1404
pubmed: 33420786
Lancet Infect Dis. 2020 Sep;20(9):1034-1042
pubmed: 32422204
J Clin Virol. 2020 Sep;130:104573
pubmed: 32769025
Heart. 2020 Oct;106(19):1503-1511
pubmed: 32737124
C R Biol. 2020 Jun 05;343(1):33-39
pubmed: 32720486
Intern Emerg Med. 2020 Aug;15(5):845-852
pubmed: 32385628
JAMA. 2020 Jul 14;324(2):195-197
pubmed: 32539107
Int J Epidemiol. 2021 Nov 10;50(5):1458-1472
pubmed: 34293141